Dorian LPG
LPG
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
eBay
EBAY
Lantheus
LNTH
US Stock MarketDetailed Quotes
TAK Takeda Pharmaceutical
- 13.110
- -0.250-1.87%
Close Dec 18 16:00 ET
41.71BMarket Cap22.30P/E (TTM)
13.370High13.110Low1.29MVolume13.340Open13.360Pre Close17.03MTurnover0.04%Turnover Ratio44.59P/E (Static)3.18BShares14.74252wk High0.93P/B39.92BFloat Cap12.29352wk Low0.63Dividend TTM3.05BShs Float19.900Historical High4.82%Div YieldTTM1.95%Amplitude11.308Historical Low13.228Avg Price1Lot Size
About Takeda Pharmaceutical Company
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Company Profile
SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49281
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.com
Company Executives
- Name
- Position
- Salary
- Akiko Amakawa
- Corporate Strategy Officer and Chief Executive Officer Chief of Staff
- --
- Christophe Weber
- Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
- 1.70B
- Takako Ohyabu
- Chief Global Corporate Affairs and Sustainability Officer
- --
- Gabriele Ricci
- Chief Data and Technology Officer
- --
- Mwana Lugogo
- Chief Ethics and Compliance Officer
- --
- Lauren Duprey
- Chief Human Resources Officer
- --
- Milano Furuta
- Director and Chief Financial Officer
- --
- Marcello Agosti
- Global Business Development Officer
- --
- Elaine Shannon
- Global Quality Officer
- --
- Dr. Thomas Wozniewski, PhD
- Global Manufacturing and Supply Officer
- --
- Julie Kim
- President, U.S. Business Unit and U.S. Country Head
- --
- Giles Platford
- President, Plasma-Derived Therapies Business Unit
- --
- Teresa Marie Bitetti
- President, Global Oncology Business Unit
- --
- Andrew S. Plump, M.D.
- Director and President, Research and Development
- 12.00M
- Asuka Miyabashira
- President, Japan Pharma Business Unit
- --
- Masami Iijima
- Chairman of the Board
- 43.00M
- Ramona Sequeira
- President, Global Portfolio Division
- --
- Emiko Higashi
- Independent Director
- 49.00M
- Ian T. Clark
- Independent Director
- 44.00M
- Dr. John M. Maraganore,PhD
- Independent Director
- 39.00M
- Kimberly A. Reed
- Independent Director
- 41.00M
- Dr. Steven Gillis, Pd.D
- Independent Director
- 44.00M
- Koji Hatsukawa
- Independent Director
- 43.00M
- Miki Tsusaka
- Independent Director
- 32.00M
- Jean-Luc Butel
- Independent Director
- 38.00M
- Michel Orsinger
- Independent Director
- 46.00M
- Yoshiaki Fujimori
- Independent Director
- 40.00M
- Yoshihiro Nakagawa
- Global General Counsel
- --
